AAAAAA
Results:
1-9
|
Results: 9
Authors:
Quilitz, RE
Arnold, AD
Briones, GR
Dix, SP
Ippoliti, C
Kennedy, LD
Lucich, JL
Mehta, J
Peters, BG
Tice, DS
Citation: Re. Quilitz et al., Practice guidelines for lipid-based amphotericin B in stem cell transplantrecipients, ANN PHARMAC, 35(2), 2001, pp. 206-216
Authors:
Dix, SP
Citation: Sp. Dix, Onsite wastewater treatment: A technological and management revolution part 1, WATER ENG M, 148(9), 2001, pp. 24
Authors:
Dix, SP
Citation: Sp. Dix, Onsite wastewater treatment. A technological and management revolution: Part 2, WATER ENG M, 148(10), 2001, pp. 22-23
Authors:
Dix, SP
Geller, RB
Citation: Sp. Dix et Rb. Geller, High-dose chemotherapy with autologous stem cell rescue in the outpatient setting, ONCOLOGY-NY, 14(2), 2000, pp. 171
Authors:
Dix, SP
Andriole, VT
Citation: Sp. Dix et Vt. Andriole, Lipid formulations of amphotericin B, CURR CLIN I, 20, 2000, pp. 1-23
Authors:
Bishop, MR
Tarantolo, SR
Geller, RB
Lynch, JC
Bierman, PJ
Pavletic, ZS
Vose, JM
Kruse, S
Dix, SP
Morris, ME
Armitage, JO
Kessinger, A
Citation: Mr. Bishop et al., A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation, BLOOD, 96(1), 2000, pp. 80-85
Authors:
Dix, SP
Cord, MK
Howard, SJ
Coon, JL
Belt, RJ
Geller, RB
Citation: Sp. Dix et al., Safety and efficacy of a continuous infusion, patient controlled antiemetic pump to facilitate outpatient administration of high-dose chemotherapy, BONE MAR TR, 24(5), 1999, pp. 561-566
Authors:
Geller, RB
Dix, SP
Citation: Rb. Geller et Sp. Dix, Oral chemotherapy agents in the treatment of leukaemia, DRUGS, 58, 1999, pp. 109-118
Authors:
Camp, MJ
Wingard, JR
Gilmore, CE
Lin, LS
Dix, SP
Davidson, TG
Geller, RB
Citation: Mj. Camp et al., Efficacy of low-dose dopamine in preventing amphotericin B nephrotoxicity in bone marrow transplant patients and leukemia patients, ANTIM AG CH, 42(12), 1998, pp. 3103-3106
Risultati:
1-9
|